Tilray Brands (TLRY) USPTO patents

Stable liquid formulations dominant in cannabidiol (CBD) can be manufactured by a sequential process of purification to create a formulation that does not crystallize under a variety of storage and use conditions, and without the use of potentially harmful additives.

The present invention relates to a kit comprising: a) an ampoule; b) a material comprising a hemp plant or parts thereof; and c) a color indicator capable of reacting by contacting the hemp plant and/or at least a part thereof to change the color of the color indicator, wherein the material and the color indicator are disposed in the ampoule; and a method for qualitatively and/or quantitatively detecting one or more substance(s) contained in the hemp plant using the kit.

Methods and apparatuses for reducing the bioburden of cannabis using low-pressure radiant energy processing.

An oral disintegrating film including a cannabinoid or cannabinoid analogue, a first film forming polymer and a solubilizing agent are disclosed as well as methods of using same.

The present disclosure describes various novel compositions and methods, wherein said compositions and methods comprise CBD and THC in certain relative ratios.

A formulation containing a cannabinoid or cannabinoid analogue in a delivery system, wherein the delivery system includes a mixture of at least one lipid and at least one surfactant, wherein the formulation self-emulsifies in an aqueous medium.

The invention provides a formulation of cannabidiol and delta-9-tetrahydrocannabinol.

Compositions for administering cannabinoid, including edible forms of cannabinoids.